Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)

Hermosilla, J; Sanchez-Martin, R; Perez-Robles, R; Salmeron-Garcia, A; Casares, S; Cabeza, J; Cuadros-Rodriguez, L; Navas, N

Navas, N (reprint author), Univ Granada, Dept Analyt Chem, Sci Fac, Biomed Res Inst Ibs Granada, Fuentenueva Ave S-N, E-18071 Granada, Spain.

BIODRUGS, 2019; 33 (2): 193

Abstract

BackgroundThere are two products in which infliximab is the active pharmaceutical ingredient. These are Remicade((R)) (INF; reference product) and Rem......

Full Text Link